IMAN: An Integrated Colorimetric Sensor for Direct Detection of PD-L1 on Extracellular Vesicles in Lung Cancer Diagnosis
- 23 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (43) , 59025-59034
Abstract
Lung cancer is a leading cause of cancer mortality, yet early diagnosis remains difficult, highlighting the need for sensitive, noninvasive methods. Extracellular vesicles (EVs) and their surface proteins (e.g., PD-L1) are promising biomarkers; nevertheless, current EV detection requires time-consuming purification, sophisticated instrumentation, and long measurement protocols, resulting in high expenses and operational difficulties. This study developed an integrated colorimetric sensor, IMAN, based on a strategy of “Immunomagnetic Microbeads (IM) capture + Aptamer(Apt) recognition + Nanozyme (N) catalysis”. IMAN employs magnetic beads modified with antibodies against CD9 and CD81 to directly capture EVs from serum, eliminating the need for time-consuming prior isolation; combined with a one-step colorimetric readout, the entire workflow can be completed with only ∼40 min of hands-on time, requiring no complex instrumentation. The PD-L1 protein on the EV surface is specifically recognized by a nanoparticle-bound nucleic acid aptamer. Signal generation is achieved through the catalytic oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) by a platinum-gold bimetallic nanozyme (Pt@Au). The facile IMAN colorimetric method demonstrated a relatively broad dynamic range (107–1010 particles/mL), high specificity (unaffected by 100 pg/mL soluble PD-L1 in serum), and reproducibility (relative standard deviation, RSD = 9.1%). Analysis of clinical serum samples revealed significantly elevated EV-PD-L1 levels in patients with lung cancer compared with healthy donors and patients with benign nodule (p < 0.01). Receiver operating characteristic (ROC) analysis yielded areas under the curve (AUC) of 0.849 for distinguishing patients with lung cancer from healthy donors and 0.860 for distinguishing patients with lung cancer from patients with benign nodules, which are superior to those of the conventional serum biomarkers CEA and Cyfra21-1. By addressing the cost, complexity, and slow response of current methods, IMAN offers a simple, cost-effective platform for direct EV surface protein detection without complex instrumentation, providing a novel tool for the noninvasive lung cancer diagnosis.Keywords
Funding Information
- National Natural Science Foundation of China (12374406)
- Natural Science Foundation of Beijing Municipality (7252049)
- Natural Science Foundation of Beijing Municipality (L259061)
- Chinese Academy of Medical Sciences (2025-JKCS-10)
- National Key Research and Development Program of China (2023YFF0714505)
- National Key Research and Development Program of China (2024YFA1209400)
This publication has 35 references indexed in Scilit:
- A Bioinspired Three‐Dimensional High‐Curvature Nano‐Interface Integrated Microfluidic Chip for Small Extracellular Vesicles Enrichment and Machine Learning‐Assisted Prostate Cancer Precision DiagnosisAdvanced Science, 2026
- Extracellular Vesicle Protein Panel Enables Early Lung Cancer Detection in a Large Clinical CohortJournal of Extracellular Vesicles, 2025
- Point-of-care detection of prostate cancer through surface protein profiling on extracellular vesicles using colorimetric 3D paper-based analytical devicesBiosensors and Bioelectronics, 2025
- Highly sensitive and portable detection of PD-L1+ exosomes using a smartphone-assisted colorimetric sensorBiosensors and Bioelectronics, 2025
- Proximity-induced amplification cascade for accurate and sensitive colorimetric detection of tumor-derived exosomesSensors and Actuators B: Chemical, 2025
- Rapid and unbiased enrichment of extracellular vesicles via a meticulously engineered peptideBioactive Materials, 2025
- Research progress of nanozymes in colorimetric biosensing: Classification, activity and applicationChemical Engineering Journal, 2024
- Homogeneous, Low‐volume, Efficient, and Sensitive Quantitation of Circulating Exosomal PD‐L1 for Cancer Diagnosis and Immunotherapy Response PredictionAngewandte Chemie International Edition, 2020
- Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead‐Assisted Flow Cytometry Detection of Tumor‐Derived Extracellular VesiclesSmall Methods, 2018
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006